Masayuki Akimoto
Overview
Explore the profile of Masayuki Akimoto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
63
Citations
672
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Shibata Y, Ohara K, Matsumoto K, Hasegawa T, Akimoto M
J Nutr Sci Vitaminol (Tokyo)
. 2021 Jul;
67(3):201-209.
PMID: 34193680
More than fifty cultivated varieties of blueberries are grown under the same processing conditions on the farm at Chiba Prefectural Agricultural College in Japan. The fruits from 51 blueberry cultivars,...
12.
Miyamoto N, Kiritoshi S, Akamime R, Akimoto M
Int Ophthalmol
. 2021 May;
41(9):3081-3086.
PMID: 33948807
Purpose: To evaluate the use of the two-hole technique in augmenting the efficiency of surgeons-in-training when performing the phaco-chop technique. We hypothesized that drilling two holes in opposite angles to...
13.
Akamine R, Miyamoto N, Kiritoshi S, Kusaka M, Akimoto M
Clin Ophthalmol
. 2021 Mar;
15:769-774.
PMID: 33654375
Background: We previously reported a novel technique using an elastic silicone bowl, which was handmade from a phaco test chamber, to salvage dislocated lenses and perform phacoemulsification and aspiration (PEA)...
14.
Matsumoto K, Hasegawa T, Ohara K, Kamei T, Koyanagi J, Akimoto M
Xenobiotica
. 2020 Nov;
51(2):155-166.
PMID: 33146575
Nabumetone (NAB) is a non-steroidal anti-inflammatory drug used clinically, and its biotransformation includes the major active metabolite 6-methoxy-2-naphthylacetic acid (6-MNA). One of the key intermediates between NAB and 6-MNA may...
15.
Matsumoto K, Hasegawa T, Ohara K, Takei C, Kamei T, Koyanagi J, et al.
Xenobiotica
. 2019 Dec;
50(7):783-792.
PMID: 31855101
The pathway for the transformation of the prodrug nabumetone, 4-(6-methoxynaphthalen-2-yl)butan-2-one, to the active metabolite 6-methoxy-2-naphthylacetic acid (6-MNA), a potent cyclooxygenase-2 inhibitor, has not yet been clarified in humans.To confirm the...
16.
Kusaka M, Miyamoto N, Akimoto M
J Cataract Refract Surg
. 2019 Oct;
45(11):1531-1534.
PMID: 31585854
Three patients with iridodialysis were recruited. A 6-0 polypropylene suture was cut to the proper length and flanged by cautery. A long (19.0 mm), ultrathin 30-gauge needle was inserted in...
17.
Miyamoto N, Yamakawa M, Akimoto M
Case Rep Ophthalmol
. 2019 May;
10(1):53-60.
PMID: 31097945
We report two cases of aphakia in whom an intraocular lens (IOL) was intrasclerally fixated through the pars plana to minimize further corneal endothelial damage. A modified lock-and-lead technique was...
18.
Kamei T, Kimura Y, Koyanagi J, Matsumoto K, Hasegawa T, Akimoto M, et al.
Chem Pharm Bull (Tokyo)
. 2019 Jan;
67(1):75-78.
PMID: 30606953
The absolute configuration of (+)-4-(6-methoxy-2-naphthyl)butan-2-ol ((+)-MNBO), a nabumetone metabolite, was determined using 1-fluoroindan-1-carboxylic acid (FICA). Both enantiomers of the FICA methyl esters were derivatized to diastereomeric esters of (+)-MNBO by...
19.
Kiritoshi S, Kusaka M, Akimoto M
Retina
. 2018 Jul;
39 Suppl 1:S58-S61.
PMID: 30044266
No abstract available.
20.
Kusaka M, Kujime Y, Yamakawa M, Akimoto M
Eur J Ophthalmol
. 2018 Jun;
29(4):458-463.
PMID: 29877117
Purpose: To develop a new technique for the placement of a Baerveldt glaucoma implant tube through a long scleral tunnel. Materials And Methods: Patients with refractory glaucoma undergoing the maximum...